Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 810-156-9 | CAS number: 1236049-43-6
Endpoint summary
Administrative data
Description of key information
LD50 (oral,rat): > 2000 mg/kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- GLP guideline study
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In an acute oral toxicity study performed according to the Acute Toxic Class method, 2000 mg/kg of the test item (R-)-3-Ammomium-1-hydroxybutyl (S)-mandelat (preparations in deionized water) were administered by gavage to two test groups of three fasted Wistar rats each (6 females). Neither mortality nor clinical signs were observed in the first and second test group dosed with 2000 mg/kg bw. The body weights of the surviving animals increased within the normal range in the first observation week with one exception. One female animal of the second test group showed stagnation of body weight. During the second week, in four out of six animals (two in each test group) stagnation of body weight was observed, while the two remaining animals revealed a normal body weight increase.This effect is observed at times in the rat strain used, because in the required age range the female animals have already reached the phase of slow growth. There were no macroscopic pathological findings in all animals sacrificed at the end of the observation period. The acute oral LD50was calculated to be LD50, oral, rat > 2000 mg/kg bw.
Justification for selection of acute toxicity – oral endpoint
only available study
Justification for classification or non-classification
No need for classification according to the EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
